August 3rd, 2010
Building on Your Success
Harlan M. Krumholz, MD, SM
Welcome to the remodeled CardioExchange: We hope you like our new look! In our efforts to develop a website that promotes learning and discussion about our rapidly evolving field, we’ve been listening and learning.
We have many new features. Some of the most prominent are:
- You can now see all of the activity on the site from the new homepage, including newly uploaded posts and comments.
- You can now make anonymous comments. Many people think this may foster more discussion. We are eager to see whether that happens.
- You can now “follow” the people, blogs, and topics that interest you the most and receive email notifications when new activity takes place.
With all these changes, our philosophy and approach remain the same. We want to be a credible, trustworthy source of information and a venue for the exchange of views and perspectives. We want to give you access to the various ways people are thinking about new (and old) information in medicine — and provide you the opportunity to learn from each other.
And we are not done listening. We will continue to learn from what you say on and do with CardioExchange, as well as from your direct feedback. Ultimately, the site is a facilitator; it is the people who make CardioExchange. We will be encouraging you to be more involved and to try out the various features. And we ask you to bring in others to participate. The site ultimately belongs to the community — and it is up to all of us to define it.
Categories: General
Tags: CardioExchange, social media
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Utah’s Prescription-Renewal Pilot Program — Autonomous AI Managing Patient Care April 23, 2026Utah recently rolled out a pilot program involving an AI system that autonomously renews certain prescriptions for people with chronic conditions. This program raises important clinical and legal issues.
- Double Take: HFpEF Explained — Prevalence, New Advances, and How to Diagnose April 23, 2026This Double Take video reviews heart failure with preserved ejection fraction, its risk factors and causes, and the challenge in establishing the diagnosis.
- Blood-Pressure Control after Intracerebral Hemorrhage — An Unbroken Glass Ceiling April 23, 2026Effective blood-pressure control is the cornerstone of management after intracerebral hemorrhage; it is both the primary determinant of risk and the most vital intervention for reducing the threat of a second vascular event.1 Yet, despite the availability of effective treatments, blood pressure remains poorly controlled in survivors of...
- Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage April 23, 2026Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo.
- Glucocorticoids in Kawasaki Disease — Refining Indications and the Science April 16, 2026Kawasaki disease is the most common cause of acquired heart disease in children in the developed world.1 Although Kawasaki disease manifests with acute, transient systemic signs, its long-term morbidity derives from necrotizing vasculitis that predominantly affects the coronary arteries.2,3 The primary goal of therapy during the...
- Utah’s Prescription-Renewal Pilot Program — Autonomous AI Managing Patient Care April 23, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
